Active Clinical Trials
|
Study ID |
PI |
Currently Enrolling |
Description |
Contact Information |
NCT03971071
|
Ferguson |
Yes |
(AMGEN) A Phase 4, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Chronic Migraine and Medication Overuse Headache |
Daniell Gallagher |
NCT03012776 |
Phan |
Yes |
(TOPS IDE) A Clinical Study to Assess the Safety and Effectiveness of the Premia Spine TOPS™ System. |
Daniell Gallagher |
NCT04032093 |
Keblawi |
No |
(Matisse) A Phase 2B Placebo-Controlled, Randomized Study of a Respiratory Syncytial Virus (RSV) Vaccine in Pregnant Women |
Hillary Salava |
NCT03926130 |
Sundaram |
Yes |
(VIVID-1 AMAM) A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease |
Nicole Finley |
NCT04329780 |
Nease |
No |
A Retrospective Multicenter Comparison of Laparoscopic and Robotic-Assisted Roux-en-Y Gastric Bypass and Sleeve Gastrectomy (Retro Bariatric) |
Daniell Gallagher |
NCT04140305 |
Ferguson |
Yes |
(ENLIGHTEN) A Multicenter, Longitudinal, Open-Label, Single-Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod |
David Coates |
NCT04173273 |
Sundaram |
Yes |
(CULTIVATE) Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease |
Nicole Finley |
NCT03616821 |
Sundaram |
Yes |
[EXPEDITION] An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis |
Nicole Finley |
NCT03537508 |
Shields |
No |
(MET 42) Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US |
Gina Finley |
NCT03759288 |
Sundaram |
Yes |
(Intrepid) An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease |
Nicole Finley |
NCT04396236 |
Lopez |
Yes |
(PIONEER-PEDS1) A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine |
David Coates |
NCT04396574 |
Lopez |
Yes |
(PIONEER-PEDS2) A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine |
David Coates |
NCT04506190 |
Nease |
Yes |
(ISI-dVBAR-002) A Prospective Multicenter Study to Evaluate the Perioperative Outcomes of Laparoscopic and Robotic-assisted Revisional Bariatric Surgery |
Daniell Gallagher |
Protocol I5Q-MC-B004 |
Ferguson |
Yes |
(TRIUMPH) Preventive Treatment of migraine: Outcomes for Patients in real-world Healthcare systems |
Daniell Gallagher |
TP-201920 |
Gentile |
Yes |
(Trauma Screw) An Observational Study to Gather Real-World Data on the Tyber Medical Trauma Screw System |
Daniell Gallagher |
P255-501 |
Lopez |
Yes |
(ROAR) A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy® XR in the Prevention of Migraine in Children 6 to 11 Years of Age |
David Coates |
NCT04320940 |
Massey |
Yes |
A Randomized, Double-Blind, Controlled Study to Assess the Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures |
Gina Finley |
N/A |
Villa |
Yes |
(KEEP)An Exploratory, Multicenter, Randomized, Double-Blind Study of Clinical Outcomes, Tolerability, and Safety of 2 Doses of Oral Pantoprazole in Pediatric Participants, Aged 1 to 11 Years and 12 to 17 Years Who Require Maintenance Therapy for Healed Erosive Esophagitis |
David Coates |
NTC04938830 |
Shields |
Yes |
A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab- Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease |
Gina Finley |
CLP-001 |
Webb |
Yes |
(RESET-RA) A Randomized, Sham-Controlled, Double-Blind Study of Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis |
Daniell Gallagher |